Pixelgen Technologies
PrivateLast Round
Series B
Aug 20, 2026
Total Funding Raised
$43.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Pixelgen Technologies operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was a Series B round in August 2026.
Pixelgen Technologies is a biotechnology company that develops and provides bio-analytical tools for spatial proteomics and biomedical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Data Visualization
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pixelgen Technologies Comparables
Compare Pixelgen Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syncell | 81% | |
| Bio-Techne Corporation | 76% | |
| Vizgen | 74% |
For institutional investors. Book with your work email.
Pixelgen Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 20, 2026 | ||||
| Grant | Jun 30, 2025 | ||||
| Series A | Oct 9, 2023 | ||||
| Seed | Dec 7, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pixelgen Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Colibri Ventures | Seed |
| Navigare Ventures | Series B, Series A, Seed |
| Industrifonden | Series B, Series A |
| Flat Capital | Series B |
| European Innovation Council (EIC) Accelerator | Grant |
| European Innovation Council Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
$16M round led by Flat Capital
- Apr 2, 2026
Building a new end-to-end cloud analysis platform for researchers.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingAug 22, 2026
Pixelgen Technologies receives $5.99M financing in Dec '22 before coming out of stealth, while the Stockholm-based company raises €13.26M led by Flat Capital on Aug 22nd '26 to expand its nanoscale cell-surface protein mapping.
- hiresAug 20, 2026
Alongside financing, Pixelgen Technologies adds Flat Capital CEO Rickard El Tarzi to its board of directors.
- hiresAug 20, 2026
Pixelgen Technologies adds life sciences industry veteran Ramon Felciano, Ph.D., to its board of directors alongside financing on Aug 20th '26.
For institutional investors. Book with your work email.
Pixelgen Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pixelgen Technologies's valuation, stock price, and market status.
Is Pixelgen Technologies a public or private company?
Pixelgen Technologies is a private company.
What is the current stock price of Pixelgen Technologies?
Pixelgen Technologies is a private company, so its shares have no public market price. Caplight tracks Pixelgen Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pixelgen Technologies worth (valuation)?
Valuation information for Pixelgen Technologies is not publicly available.
Can I buy Pixelgen Technologies stock?
Pixelgen Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pixelgen Technologies's last funding round?
Pixelgen Technologies's most recent funding round was Series B on August 20, 2026.
Who are the main investors in Pixelgen Technologies?
Key investors in Pixelgen Technologies include European Innovation Council Fund, Navigare Ventures, Industrifonden, Flat Capital, European Innovation Council (EIC) Accelerator.
Will Pixelgen Technologies IPO soon?
No public IPO plans have been announced for Pixelgen Technologies.
How can I track Pixelgen Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Pixelgen Technologies's shares on secondary markets.